The word “hermaphrodite” refers to an ancient, often mythological imagination. In biological reality, the medical term used today is “intersex.” It designates individuals born with sexual characteristics that do not fit the classical definitions of male or female. Recent developments, both legally and medically, are reshaping the way society approaches these issues.
Intersex and Terminology: Why the Word Hermaphrodite is Declining
For centuries, the word “hermaphrodite” was used to refer to anyone exhibiting variations in sexual characteristics. This term, inherited from the Greek myth of Hermaphroditus, son of Hermes and Aphrodite, carried with it a burden of curiosity and marginalization.
The affected communities and medical institutions now prefer the term intersex or variations in sexual development. This shift is not cosmetic. It reflects a change in perspective: moving from an “anomaly” to a natural variation of the human body.
According to specialists, between 0.05% and 1.7% of the population is born with intersex traits. The higher estimate corresponds to a proportion comparable to that of red-haired individuals. This broad figure is explained by the diversity of the variations involved: chromosomal, hormonal, anatomical.
Following the news on Hermaphrodite helps to better understand these semantic evolutions and their concrete translation in law and medicine.
French Observatory of Intersex in Sports: A Recent Creation
In France, the subject has taken on a new public dimension with high-level sports. The controversies surrounding gender tests during international competitions have highlighted the gray areas of the binary classification of athletes.
France has created an observatory for intersex and identity in sports, established by Marina Ferrari. This structure aims to inform public authorities’ choices regarding intersex and transgender athletes, without limiting itself to a purely sports framework.
Why does this initiative matter? Because sports is one of the few areas where the binary classification of sexes has direct, measurable, and contested consequences. International sports regulations sometimes impose hormonal thresholds that directly affect the careers of intersex athletes, often without their informed consent.
This observatory marks a different approach from that of many European countries. France positions itself against systematic gender testing, preferring a broader analytical framework that integrates the fundamental rights of the individuals concerned.
Rights of Intersex Individuals in Europe: Uneven Progress
The European legal framework is evolving, but in a disparate manner. Several axes of change have emerged in recent years.
Protection Against Non-Consensual Medical Interventions
International recommendations, particularly those from the United Nations, urge states to prohibit medically unnecessary surgeries on intersex infants and children. These operations, sometimes performed within the first months of life, aim to conform the child’s body to a male or female appearance. They are increasingly denounced as violations of fundamental rights.
In France, a report commissioned by the DILCRAH documented the psychological and physical consequences of these interventions. However, the issue remains politically sensitive, and no specific law currently formally prohibits these practices in French territory.
Gender Mention in Civil Status
Germany is a pioneer in Europe. The country has allowed the registration of a “diverse” mention in civil status for several years. Data from Destatis (the federal statistical office) show a steady increase in requests for gender change, indicating that the system meets a real need.
In France, the civil code does not provide for a third gender option. Intersex individuals wishing to modify their civil status must go through a judicial process, often lengthy and uncertain.
- Germany has offered a “diverse” mention in civil status for several years, with an increasing number of requests recorded.
- Belgium is working to guarantee the rights of intersex individuals, as documented by Amnesty International in a report dedicated to the subject.
- In France, no specific legislation protects intersex children from non-consensual surgical interventions, despite international recommendations.
Mental Health and Intersex: An Under-Documented Angle
The consequences of early interventions are not limited to the body. Intersex individuals face mental health issues that are often made invisible. Psycom, the French public organization for mental health information, now includes intersex individuals in its resources dedicated to LGBT+ populations.
The problem goes beyond the surgical question. The lack of legal recognition, the medical secrecy imposed during childhood, and the absence of identified peers create a specific isolation. Have you ever noticed that most LGBT+ awareness campaigns rarely mention the “I” in the acronym? This invisibility has measurable effects on access to care and psychological support.
Recent recommendations emphasize the need for specific complaint and accountability mechanisms for violations of the rights of intersex individuals. These mechanisms do not yet exist in most European countries.
Research and Intersex: What is Still Missing
A recurring point in all recent institutional publications is the lack of data. Epidemiological studies on intersex individuals remain rare. Prevalence estimates vary by a factor of thirty depending on the criteria used, complicating any evidence-based public policy.
The guidelines published in 2024 by the United Nations explicitly recommend that states conduct systematic research and assessments on the rights violations suffered by intersex individuals. Without this data, lawmakers proceed cautiously.
The book by Michal Raz, “Intersex: From Medical Power to Self-Determination,” published by Éditions du Cavalier bleu, illustrates this gradual shift from an interventionist medical paradigm to an approach based on rights and consent. This type of academic work is now fueling public debate, beyond activist circles.
The topic of intersex is slowly emerging from medical obscurity to enter the realm of law and social recognition. The coming years will tell whether international recommendations translate into concrete laws, in France and elsewhere in Europe.